⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbamic Acid SCHEMBL2268424 | 0.83 | GABRP (0.35) | — | |
| SCHEMBL27938032 | 0.77 | — | — | |
| SCHEMBL8308592 | 0.77 | MAP2K1 (0.38) | — | |
| SCHEMBL279674 | 0.76 | — | — | |
| SCHEMBL30190024 | 0.74 | PIN1 (0.47) | — | |
| SCHEMBL31263227 | 0.72 | CSF1R (0.42) | — | |
| SCHEMBL4372514 | 0.72 | DAO (0.40) | — | |
| SCHEMBL24898305 | 0.71 | ALDH1A1 (0.53) | — | |
| SCHEMBL7785716 | 0.71 | HDAC1 (0.31) | — | |
| SCHEMBL3806313 | 0.71 | HRH1 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1178796-A4 | SALTS OF AMINOIMIDAZOLE CARBOXAMIDE USEFUL IN THE PREVENTION AND TREATMENT OF LIVER DISEASES | SAVVIPHARM INC (US) | 2004-07-14 | — | — | EP | claimed |
| JP-2003526624-A | — | — | 2003-09-09 | — | — | JP | claimed |
| EP-1178796-A1 | SALTS OF AMINOIMIDAZOLE CARBOXAMIDE USEFUL IN THE PREVENTION AND TREATMENT OF LIVER DISEASES | Savvipharm Inc. (US) | 2002-02-13 | — | — | EP | claimed |
| US-6184227-B1 | ADMINISTERING A DETOXIFYING DOSAGE TO PATIENT TO PREVENT TISSUE DAMAGE BY ALCOHOLIC BEVERAGES, REACTIVE DRUG METABOLITES OR DIETARY TOXINS | SAVVIPHARM INC. | 2001-02-06 | — | — | US | claimed |
| WO-2000078311-A1 | SALTS OF AMINOIMIDAZOLE CARBOXAMIDE USEFUL IN THE PREVENTION AND TREATMENT OF LIVER DISEASES | SAVVIPHARM INC. (US) | 2000-12-28 | — | — | WO | claimed |
| CN-109952380-B | Method for producing target substance | 味之素株式会社 | 2023-07-14 | — | — | CN | disclosed |
| CN-109937257-B | Method for producing target substance | 味之素株式会社 | 2023-06-30 | — | — | CN | disclosed |
| US-9487763-B2 | Nonribosomal peptide synthetases | REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2016-11-08 | — | — | US | disclosed |
| US-20150361470-A1 | NONRIBOSOMAL PEPTIDE SYNTHETASES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2015-12-17 | — | — | US | disclosed |
| CN-103619332-A | Acadesine derivatives, products and compositions including same, therapeutic uses thereof, and methods for synthesizing same | UNIV NICE SOPHIA ANTIPOLIS | 2014-03-05 | — | — | CN | disclosed |
| US-20130131072-A1 | Methods for Optimizing Clinical Responsiveness to Methotrexate Therapy Using Metabolite Profiling and Pharmacogenetics | PROMETHEUS LABORATORIES INC. | 2013-05-23 | — | — | US | disclosed |
| US-8288158-B2 | Stem cells modified to facilitate threonine catabolism | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2012-10-16 | — | — | US | disclosed |
| WO-2000078311-A1 | SALTS OF AMINOIMIDAZOLE CARBOXAMIDE USEFUL IN THE PREVENTION AND TREATMENT OF LIVER DISEASES | SAVVIPHARM INC. (US) | 2000-12-28 | — | — | WO | disclosed |
| US-5912346-A | Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles | CONSTANTIA GRUPPE (AT) | 1999-06-15 | — | — | US | disclosed |
| US-5861396-A | CARDIOVASCULAR DISORDERS AND UROGENITAL SYSTEMS | BAYER AKTIENGESELLSCHAFT (DE) | 1999-01-19 | — | — | US | disclosed |
| US-5861406-A | ANTICARCINOGENIC AGENTS AND ANTITUMOR AGENTS | CONSTANTIA GRUPPE (AT) | 1999-01-19 | — | — | US | disclosed |
| EP-0840608-A1 | TREATMENT AND PREVENTION OF NEOPLASMS WITH SALTS OF AMINOIMIDAZOLE CARBOXAMIDE AND 5-AMINO OR SUBSTITUTED AMINO 1,2,3-TRIAZOLES | Constantia Gruppe (AT) | 1998-05-13 | — | — | EP | disclosed |
| US-5728707-A | Treatment and prevention of primary and metastatic neoplasms with salts of aminoimidazole carboxamide | CONSTANTIA GRUPPE (AT) | 1998-03-17 | — | — | US | disclosed |
| EP-0771799-A1 | Purin-6-one derivatives | BAYER AG (DE) | 1997-05-07 | — | — | EP | disclosed |
| WO-1997003668-A1 | TREATMENT AND PREVENTION OF NEOPLASMS WITH SALTS OF AMINOIMIDAZOLE CARBOXAMIDE AND 5-AMINO OR SUBSTITUTED AMINO 1,2,3-TRIAZOLES | CONSTANTIA GRUPPE (AT) | 1997-02-06 | — | — | WO | disclosed |